An eyelash lengthening product manufactured by Jan Marini Skin Research (JMSR) has been removed from the market. This was due to fears over the FDA's standpoint on products which blur the line between cosmetics and drugs. It has already suspended its US sales. The withdrawal of this product was voluntary. It came after the FDA seized the product's predecessor the Age Intervention Eyelash Enhancer.

Product Highlights
a. The original product contained bimatoprost, which is approved by the FDA for glaucoma treatment.
b. The regulatory body called the product an unapproved and misbranded drug.
c. The reformulated product does not contain bimatoprost.
d. However, it blurs the line between cosmetics and drugs.